Theragnostics in prostate cancer
The objective of this comprehensive review is to highlight the recent advances in PCa theragnostics, focusing on actual clinical applications and future perspectives.PMID:35133097 | DOI:10.23736/S1824-4785.21.03419-1
Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Authors: Andrea Farolfi Riccardo Mei Sakaria Ali Paolo Castellucci Source Type: research
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | New Drug Applications | Nuclear Medicine | Prostate Cancer | Radiography | Study